The Coming Intersection of Nanotechnology and Synthetic Biology With Insurance
April 24, 2009
Foley Partner and chair of the Health Care Industry Team Mark Waxman and Partner Ethan Lenz authored an article titled, “The Coming Intersection of Nanotechnology and Synthetic Biology With Insurance,” in the April 24, 2009 issue of BNA’s Life Sciences Law & Industry Report.
Reproduced with permission from BNA’s Life Sciences Law & Industry Report, by The Bureau of National Affairs, Inc. http://www.bna.com.
Author(s)
Related Insights
July 10, 2025
Foley Viewpoints
One Big Beautiful Bill Act Permanently Increases the Lifetime Estate, Gift and GST Tax Exclusion
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (OBBBA). The OBBBA extended and may permanent many key…
July 10, 2025
Foley Viewpoints
FTC's "Click-to-Cancel" Rule Invalidated
The Federal Appeals Court for the 8th Circuit invalidated the Federal Trade Commission's (FTC) “click-to-cancel” (aka “negative option”)…
July 10, 2025
Foley Viewpoints
Trump Administration Passes the One Big Beautiful Bill Act
On July 4, 2025, President Trump signed H.R. 1—referred to as the One Big Beautiful Bill Act (OBBBA). The OBBBA extends and makes…